CONTENTS:
- Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection. Grebely J., Robaeys G., Bruggmann P., Aghemo A., Backmund M., Bruneau J., et al., art. 101669.
- Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden. Grebely J., Robaeys G., Bruggmann P., Aghemo A., Backmund M., Bruneau J., et al., art. 101670.
- Recomendaciones para el manejo de la infeccion por el virus de la hepatitis C entre usuarios de drogas por via parenteral. Grebely J., Robaeys G., Bruggmann P., Aghemo A., Backmund M., Bruneau J., et al., art. 101671.
- Spotting as a risk mitigation method: A qualitative study comparing organization-based and informal methods. Perri M., Guta A., Kaminski N., Bonn M., Kolla G., Bayoumi A., et al., art. 103905.
- Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use. Spaderna M., Kattakuzhy S., Kang S.J., George N., Bijole P., Ebah E., et al., art. 103906.
- Incarceration history, antiretroviral therapy, and stigma: A cross-sectional study of people with HIV who inject drugs in St. Petersburg, Russia. Bovell-Ammon B.J., Kimmel S.D., Cheng D.M., Truong V., Michals A., Vetrova M., et al., art. 103907.
- The socio-economic context of entry and exit from retail drug dealing: Exploring the narratives of Nigerian dealers. Nelson E.-U.E., art. 103908.
- Effects of media representations of drug related deaths on public stigma and support for harm reduction. Sumnall H.R., Atkinson A., Montgomery C., Maynard O., Nicholls J., art. 103909.
- A scoping review of qualitative research on barriers and facilitators to the use of supervised consumption services. Ivsins A., Warnock A., Small W., Strike C., Kerr T., Bardwell G., art. 103910.
- Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. Cunningham E.B., Wheeler A., Hajarizadeh B., French C.E., Roche R., Marshall A.D., et al., art. 103917.
- Increased solitary drug use during COVID-19: An unintended consequence of social distancing. Schneider K.E., Allen S.T., Rouhani S., Morris M., Haney K., Saloner B., et al., art. 103923.
- Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs. Austin E.J., Gojic A.J., Bhatraju E.P., Pierce K.A., Pickering E.I., Tung E.L., et al., art. 103924.
- Trust and service engagement among people who inject drugs after release from prison. Lafferty L., Schroeder S., Marshall A.D., Drysdale K., Higgs P., Stoové M., et al., art. 103925.
- E-cigarette use in global digital youth culture. A qualitative study of the social practices and meaning of vaping among 15-20-year-olds in Denmark, Finland, and Norway. Scheffels J., Tokle R., Linnansaari A., Rasmussen S.K.B., Pisinger C., art. 103928.
- (Re)situating expertise in community-based overdose response: Insights from an ethnographic study of overdose prevention sites (OPS) in Vancouver, Canada. Olding M., Boyd J., Kerr T., Fowler A., McNeil R., art. 103929.
- Adverse outcomes of GHB use: Analysis of ambulance attendances in metropolitan and regional Victoria. Ogeil R.P., Faulkner A., Beard N., Killian J.J., Arunogiri S., Phan V., et al., art. 103932.
- The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions. Russell C., Law J., Bonn M., Rehm J., Ali F., art. 103933.
- "It's just not the same": Exploring PWUD' perceptions of and experiences with drug policy and SCS services change in a Canadian City. Greene C., Maier K., Urbanik M.-M., art. 103934.